AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-90
Results: 1-25/90
METHODS FOR EXTRACTING AND AMPLIFYING GENOMIC DNA ISOLATED FROM FROZEN SERUM
Authors: DIXON SC HORTI J GUO Y REED E FIGG WD
Citation: Sc. Dixon et al., METHODS FOR EXTRACTING AND AMPLIFYING GENOMIC DNA ISOLATED FROM FROZEN SERUM, Nature biotechnology, 16(1), 1998, pp. 91-94
ELEVATED CARCINOEMBRYONIC ANTIGEN IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER
Authors: FEUER JA LUSH RM VENZON D DURAY P TOMPKINS A SARTOR O FIGG WD
Citation: Ja. Feuer et al., ELEVATED CARCINOEMBRYONIC ANTIGEN IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER, Journal of investigative medicine, 46(2), 1998, pp. 66-72
AUGMENTED CAPILLARY LEAK DURING ISOLATED HEPATIC PERFUSION (IHP) OCCURS VIA TUMOR NECROSIS FACTOR-INDEPENDENT MECHANISMS
Authors: ALEXANDER HR BROWN CK BARTLETT DL LIBUTTI SK FIGG WD RAJE S TURNER E
Citation: Hr. Alexander et al., AUGMENTED CAPILLARY LEAK DURING ISOLATED HEPATIC PERFUSION (IHP) OCCURS VIA TUMOR NECROSIS FACTOR-INDEPENDENT MECHANISMS, Clinical cancer research, 4(10), 1998, pp. 2357-2362
PHASE-II STUDY OF SURAMIN PLUS AMINOGLUTETHIMIDE IN 2 COHORTS OF PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER - SIMULTANEOUS ANTIANDROGEN WITHDRAWAL AND PRIOR ANTIANDROGEN WITHDRAWAL
Authors: DAWSON N FIGG WD BRAWLEY OW BERGAN R COOPER MR SENDEROWICZ A HEADLEE D STEINBERG SM SUTHERLAND M PATRONAS N SAUSVILLE E LINEHAN WM REED E SARTOR O
Citation: N. Dawson et al., PHASE-II STUDY OF SURAMIN PLUS AMINOGLUTETHIMIDE IN 2 COHORTS OF PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER - SIMULTANEOUS ANTIANDROGEN WITHDRAWAL AND PRIOR ANTIANDROGEN WITHDRAWAL, Clinical cancer research, 4(1), 1998, pp. 37-44
PHASE-II STUDY OF SURAMIN PLUS AMINOGLUTETHIMIDE IN 2 COHORTS OF PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER - SIMULTANEOUS ANTIANDROGEN WITHDRAWAL AND PRIOR ANTIANDROGEN WITHDRAWAL
Authors: DAWSON N FIGG WD BRAWLEY OW BERGAN R COOPER MR SENDEROWICZ A HEADLEE D STEINBERG SM SUTHERLAND M PATRONAS N SAUSVILLE E LINEHAN WM REED E SARTOR O
Citation: N. Dawson et al., PHASE-II STUDY OF SURAMIN PLUS AMINOGLUTETHIMIDE IN 2 COHORTS OF PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER - SIMULTANEOUS ANTIANDROGEN WITHDRAWAL AND PRIOR ANTIANDROGEN WITHDRAWAL, Clinical cancer research, 4(1), 1998, pp. 37-44
A PHASE-II STUDY OF BROMOCRIPTINE IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER
Authors: HORTI J FIGG WD WEINBERGER B KOHLER D SARTOR O
Citation: J. Horti et al., A PHASE-II STUDY OF BROMOCRIPTINE IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER, Oncology Reports, 5(4), 1998, pp. 893-896
CYCLIN-DEPENDENT KINASES - TARGETS FOR NOVEL THERAPEUTIC APPROACHES
Authors: SAUSVILLE EA HEADLEE D STINSON SF LUSH RM FIGG WD ARBUCK SG SENDEROWICZ AM
Citation: Ea. Sausville et al., CYCLIN-DEPENDENT KINASES - TARGETS FOR NOVEL THERAPEUTIC APPROACHES, Annals of oncology, 9, 1998, pp. 50-50
INCREASED TRANSCRIPTIONAL ACTIVITY OF PROSTATE-SPECIFIC ANTIGEN IN THE PRESENCE OF TNP-470, AN ANGIOGENESIS INHIBITOR
Authors: HORTI J DIXON SC LOGOTHETIS CJ GUO Y REED E FIGG WD
Citation: J. Horti et al., INCREASED TRANSCRIPTIONAL ACTIVITY OF PROSTATE-SPECIFIC ANTIGEN IN THE PRESENCE OF TNP-470, AN ANGIOGENESIS INHIBITOR, Annals of oncology, 9, 1998, pp. 276-276
PHASE-I TRIAL OF INFUSIONAL UCN-01, A NOVEL PROTEIN-KINASE INHIBITOR,IN PATIENTS WITH REFRACTORY NEOPLASMS
Authors: SENDEROWICZ AM HEADLEE D LUSH R ARBUCK S BAUER K FIGG WD MURGO A INOUE K KOBASHI S KUWABARA T SAUSVILLE EA
Citation: Am. Senderowicz et al., PHASE-I TRIAL OF INFUSIONAL UCN-01, A NOVEL PROTEIN-KINASE INHIBITOR,IN PATIENTS WITH REFRACTORY NEOPLASMS, Annals of oncology, 9, 1998, pp. 426-426
PHASE-II STUDY OF CARBOXYAMIDO-TRIAZOLE (CAI) IN ANDROGEN-INDEPENDENTPROSTATE-CANCER (AIPC)
Authors: BAUER KS FIGG WD HAMILTON JM BERGAN R CHEN A DYER V WALTHER MM LINEHAN WM REED E
Citation: Ks. Bauer et al., PHASE-II STUDY OF CARBOXYAMIDO-TRIAZOLE (CAI) IN ANDROGEN-INDEPENDENTPROSTATE-CANCER (AIPC), Annals of oncology, 9, 1998, pp. 668-668
PHASE-I TRIAL OF CONTINUOUS-INFUSION FLAVOPIRIDOL, A NOVEL CYCLIN-DEPENDENT KINASE INHIBITOR, IN PATIENTS WITH REFRACTORY NEOPLASMS
Authors: SENDEROWICZ AM HEADLEE D STINSON SF LUSH RM KALIL N VILLALBA L HILL K STEINBERG SM FIGG WD TOMPKINS A ARBUCK SG SAUSVILLE EA
Citation: Am. Senderowicz et al., PHASE-I TRIAL OF CONTINUOUS-INFUSION FLAVOPIRIDOL, A NOVEL CYCLIN-DEPENDENT KINASE INHIBITOR, IN PATIENTS WITH REFRACTORY NEOPLASMS, Journal of clinical oncology, 16(9), 1998, pp. 2986-2999
PHASE-II TRIAL WITH DOSE TITRATION OF PACLITAXEL FOR THE THERAPY OF HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED KAPOSIS-SARCOMA
Authors: WELLES L SAVILLE MW LIETZAU J PLUDA JM WYVILL KM FEUERSTEIN I FIGG WD LUSH R ODOM J WILSON WH FAJARDO MT HUMPHREY RW FEIGAL E TUCK D STEINBERG SM BRODER S YARCHOAN R
Citation: L. Welles et al., PHASE-II TRIAL WITH DOSE TITRATION OF PACLITAXEL FOR THE THERAPY OF HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED KAPOSIS-SARCOMA, Journal of clinical oncology, 16(3), 1998, pp. 1112-1121
CLINICAL-PHARMACOLOGY OF UCN-01 - INITIAL OBSERVATIONS AND COMPARISONTO PRECLINICAL MODELS
Authors: SAUSVILLE EA LUSH RD HEADLEE D SMITH AC FIGG WD ARBUCK SG SENDEROWICZ AM FUSE E TANII H KUWABARA T KOBAYASHI S
Citation: Ea. Sausville et al., CLINICAL-PHARMACOLOGY OF UCN-01 - INITIAL OBSERVATIONS AND COMPARISONTO PRECLINICAL MODELS, Cancer chemotherapy and pharmacology, 42, 1998, pp. 54-59
A PHASE-II STUDY OF 5-AZA-2'DEOXYCYTIDINE (DECITABINE) IN HORMONE-INDEPENDENT METASTATIC (D2) PROSTATE-CANCER
Authors: THIBAULT A FIGG WD BERGAN RC LUSH RM MYERS CE TOMPKINS A REED E SAMID D
Citation: A. Thibault et al., A PHASE-II STUDY OF 5-AZA-2'DEOXYCYTIDINE (DECITABINE) IN HORMONE-INDEPENDENT METASTATIC (D2) PROSTATE-CANCER, Tumori, 84(1), 1998, pp. 87-89
ALTERATION IN INDINAVIR CLEARANCE DURING INTERLEUKIN-2 INFUSIONS IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: PISCITELLI SC VOGEL S FIGG WD RAJE S FORREST A METCALF JA BASELER M FALLOON J
Citation: Sc. Piscitelli et al., ALTERATION IN INDINAVIR CLEARANCE DURING INTERLEUKIN-2 INFUSIONS IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS, Pharmacotherapy, 18(6), 1998, pp. 1212-1216
EFFECT OF PREDNISONE ON PROSTATE-SPECIFIC ANTIGEN IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER
Authors: SARTOR O WEINBERGER M MOORE A LI AL FIGG WD
Citation: O. Sartor et al., EFFECT OF PREDNISONE ON PROSTATE-SPECIFIC ANTIGEN IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER, Urology, 52(2), 1998, pp. 252-256
DOWN-REGULATION OF PROSTATE-SPECIFIC ANTIGEN AND ANDROGEN RECEPTOR INLNCAP CELLS AND THE EFFECTS OF DIFFERENTIATION AGENTS ON INDUCTION OFTHESE 2 GENES
Authors: DIXON SC LEEDOM M GETEK KA ARAH IN GUO Y HORTI J FIGG WD
Citation: Sc. Dixon et al., DOWN-REGULATION OF PROSTATE-SPECIFIC ANTIGEN AND ANDROGEN RECEPTOR INLNCAP CELLS AND THE EFFECTS OF DIFFERENTIATION AGENTS ON INDUCTION OFTHESE 2 GENES, The Journal of urology, 159(5), 1998, pp. 46-46
LACK OF GLEASONS SUM EFFECT ON SURVIVAL IN PATIENTS WITH STAGE D2 PROSTATE-CANCER
Authors: VANBINGHAM W EASTHAM JA SARTOR O FIGG WD
Citation: W. Vanbingham et al., LACK OF GLEASONS SUM EFFECT ON SURVIVAL IN PATIENTS WITH STAGE D2 PROSTATE-CANCER, The Journal of urology, 159(5), 1998, pp. 1156-1156
IMMUNOLOGICAL THERAPY OF PROSTATE-CANCER WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF)
Authors: SMALL EJ WHISENANT S GUILD C FIGG WD
Citation: Ej. Small et al., IMMUNOLOGICAL THERAPY OF PROSTATE-CANCER WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF), The Journal of urology, 159(5), 1998, pp. 1293-1293
IN-VITRO GLUCURONIDATION OF FLAVOPIRIDOL (NSC649890) (FLAVO) BY HUMANLIVER-MICROSOMES
Authors: RAMIREZ J IYER L LUSH RM MORTELL M FEUER JA FIGG WD SAUSVILLE EA RATAIN MJ
Citation: J. Ramirez et al., IN-VITRO GLUCURONIDATION OF FLAVOPIRIDOL (NSC649890) (FLAVO) BY HUMANLIVER-MICROSOMES, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 50-50
UNPREDICTED CLINICAL-PHARMACOLOGY OF UCN-01 CAUSED BY SPECIFIC BINDING TO HUMAN ALPHA(1)-ACID GLYCOPROTEIN
Authors: FUSE E TANII H KURATA N KOBAYASHI H SHIMADA Y TAMURA T SASAKI Y TANIGAWARA Y LUSH RD HEADLEE D FIGG WD ARBUCK SG SENDEROWICZ AM SAUSVILLE EA AKINAGA S KUWAHARA A KOBASASHI S
Citation: E. Fuse et al., UNPREDICTED CLINICAL-PHARMACOLOGY OF UCN-01 CAUSED BY SPECIFIC BINDING TO HUMAN ALPHA(1)-ACID GLYCOPROTEIN, Cancer research, 58(15), 1998, pp. 3248-3253
A PHASE-I TRIAL OF CONTINUOUS HYPERTHERMIC PERITONEAL PERFUSION WITH TUMOR-NECROSIS-FACTOR AND CISPLATIN IN THE TREATMENT OF PERITONEAL CARCINOMATOSIS
Authors: BARTLETT DL BUELL JF LIBUTTI SK REED E LEE KB FIGG WD VENZON DJ ALEXANDER HR
Citation: Dl. Bartlett et al., A PHASE-I TRIAL OF CONTINUOUS HYPERTHERMIC PERITONEAL PERFUSION WITH TUMOR-NECROSIS-FACTOR AND CISPLATIN IN THE TREATMENT OF PERITONEAL CARCINOMATOSIS, Cancer, 83(6), 1998, pp. 1251-1261
INHIBITION OF ANGIOGENESIS BY THALIDOMIDE REQUIRES METABOLIC-ACTIVATION, WHICH IS SPECIES-DEPENDENT
Authors: BAUER KS DIXON SC FIGG WD
Citation: Ks. Bauer et al., INHIBITION OF ANGIOGENESIS BY THALIDOMIDE REQUIRES METABOLIC-ACTIVATION, WHICH IS SPECIES-DEPENDENT, Biochemical pharmacology, 55(11), 1998, pp. 1827-1834
CONTINUOUS HYPERTHERMIC PERITONEAL PERFUSION WITH CISPLATIN FOR THE TREATMENT OF PERITONEAL MESOTHELIOMA
Authors: MA GY BARTLETT DL REED E FIGG WD LUSH RM LEE KB LIBUTTI SK ALEXANDER HR
Citation: Gy. Ma et al., CONTINUOUS HYPERTHERMIC PERITONEAL PERFUSION WITH CISPLATIN FOR THE TREATMENT OF PERITONEAL MESOTHELIOMA, The cancer journal from Scientific American, 3(3), 1997, pp. 174-179
A PHASE-I TRIAL ADMINISTERING THE ANGIOGENESIS INHIBITOR TNP-470 (AGM-1470) TO PATIENTS (PTS) WITH HIV-ASSOCIATED KAPOSIS-SARCOMA (KS)
Authors: PLUDA JM WYVILL KK LIETZAU J FIGG WD WHITCUP SM FEIGAL E HUMPHREY R WELLES L YARCHOAN R
Citation: Jm. Pluda et al., A PHASE-I TRIAL ADMINISTERING THE ANGIOGENESIS INHIBITOR TNP-470 (AGM-1470) TO PATIENTS (PTS) WITH HIV-ASSOCIATED KAPOSIS-SARCOMA (KS), Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 13-13
Risultati: 1-25 | 26-50 | 51-75 | 76-90